Back to search
FDAFDA · Food and drugs·Recall number D-1436-2016

Duloxetine Delayed-Release Capsules, USP, 60 mg, 30-count bottles, Rx only, Manufactured by Apotex Inc, Toronto, Ontario M9L 1T9, Manufactured for Apotex Corp. Weston Florida 33326, NDC 60505-2997-3; UPC # 360505299737;

Published July 20, 2016 · Recall initiated: January 26, 2016

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Dissolution Specification: Out of specification dissolution results when testing product stability.

What to do

Voluntary: Firm initiated · Letter

Recall details

Manufacturer
Apotex Scientific, Inc
Distributor
Nationwide, Alaska, Hawaii, and Puerto Rico.
Lot
Lot #: KW2167,KY9960, KV9789, KV9788; Exp 02/29/2016; Lot #: KY9961, Exp 04/30/2016; Lot #: KX6311, KX6312, KY7795, KX6315, Exp 05/31/2016; Lot #: KX6317, Exp 06/30/2016.
Risk classification
Class III
Area (FDA)
drug
Country
United States

Sell products like this?

Recalert watches your whole catalog for recalls like this one, automatically.

Start free — no card